[Fibrocystic disease of breast and pituitary-thyroid axis function]

Area of Science:

• Endocrinology
• Oncology

Background:

• Benign mastopathy is a common condition affecting women.
• Thyroid hormones play a crucial role in overall health.
• Previous research has suggested potential links between thyroid function and breast health.

Purpose of the Study:

• To investigate thyroid stimulating hormone (TSH), triiodothyroxine (T3), thyroxin (T4), and prolactin (Prl) concentrations.
• To compare these hormone levels in patients with benign mastopathy versus a control group.
• To explore the relationship between benign mastopathy and thyroid function.

Main Methods:

• Blood samples were collected from patients with benign mastopathy and a control group.
• Concentrations of T3, T4, TSH, and Prl were measured.
• Statistical analysis was performed to compare hormone levels between groups.

Main Results:

• Mean T4 concentrations were significantly lower in women with benign mastopathy (78.25 +/- 15.27 ng/ml) compared to controls (88.73 +/- 15.27 ng/ml).
• Mean TSH and prolactin (Prl) concentrations were higher, though not significantly, in women with mastopathy.
• All subjects were clinically euthyroid, indicating normal thyroid status at the time of the study.

Conclusions:

• Benign mastopathy may be associated with altered thyroid function, particularly lower T4 levels.
• Further research is needed to elucidate the exact nature of the connection between benign breast conditions and thyroid hormones.
• These findings highlight the importance of considering thyroid health in the context of benign mastopathy.